Aigen Investment Management, LP

Position in ABT — Abbott Laboratories

CIK 1741224 NEW YORK, NY

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,496,257

+$3,463,808 QoQ

Shares Held

49,551

+398.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.24%

of 13F equity value

Holder Rank

#721

of 2,905 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $10,476,105 across 13 Medical Devices names. ABT ranks #1 (42.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	49,551	$4,496,257
2	MDT	Medtronic plc	24,962	$1,952,777
3	EW	Edwards Lifesciences Corp	16,910	$1,529,678
4	BSX	Boston Scientific Corp	26,161	$1,116,551
5	PODD	Insulet Corp	3,046	$463,753
6	HAE	Haemonetics Corp	3,685	$276,375
7	TMDX	TransMedics Group, Inc.	3,821	$253,790
8	QTRX	Quanterix Corp	24,328	$105,096

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,496,257	49,551	+398.7%	Shares	Sole	2026-08-14
2024-06-30	$1,032,449	9,936	+353.5%	Shares	Sole	2024-08-09
2024-03-31	$249,029	2,191	-65.3%	Shares	Sole	2024-05-14
2023-09-30	$612,188	6,321	+120.6%	Shares	Sole	2023-11-13
2023-06-30	$312,451	2,866	-96.3%	Shares	Sole	2023-08-14
2023-03-31	$7,918,025	78,195	+744.2%	Shares	Sole	2023-05-15
2022-03-31	$1,096,368	9,263	-53.0%	Shares	Sole	2022-05-05
2021-12-31	$2,772,015	19,696	-30.6%	Shares	Sole	2022-02-11
2021-09-30	$3,351,111	28,368	-49.1%	Shares	Sole	2021-11-12
2021-06-30	$6,459,735	55,721	+196.1%	Shares	Sole	2021-08-10
2020-09-30	$2,047,854	18,817	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.